MengRu Zhan

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 24, 2026
Identification of GOT1, OAF, XPNPEP2, CRISPLD2, and RPS21 as Sorafenib-Treatment-Associated Candidate Biomarkers for Hepatocellular Carcinoma.

|Dec 10, 2020
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC.

Xiuzhu Gao, Mengru Zhan, Liquan Wang

|Oct 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients.

Miaoxia Liu, Ruihong Wu, Xu Liu

|May 16, 2020
IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse Model.

Xiuzhu Gao, Xiumei Chi, Xiaomei Wang

Pageof 1

Frequent Collaborators

3 joint publications

Xiuzhu Gao

2 joint publications

Xiumei Chi

2 joint publications

Ruihong Wu

1 joint publications

Xiaomei Wang